Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Divestments (2022 - 2023)

Arcadia Biosciences (RKDA) has disclosed Divestments for 2 consecutive years, with $284000.0 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Divestments changed N/A year-over-year to $284000.0, compared with a TTM value of $284000.0 through Mar 2024, down 66.74%, and an annual FY2023 reading of $569000.0, changed 0.0% over the prior year.
  • Divestments was $284000.0 for Q2 2023 at Arcadia Biosciences, roughly flat from $285000.0 in the prior quarter.
  • Across five years, Divestments topped out at $285000.0 in Q3 2022 and bottomed at $284000.0 in Q4 2022.